Market Research Logo

Sweden Pharmaceuticals and Healthcare Report Q1 2016

Sweden Pharmaceuticals and Healthcare Report Q1 2016

BMI View: We continue to view Sweden as a moderately attractive regional market. The proportion of thecountry's pensionable population is on the rise and coupled with high per capita spending, multinationalpharmaceutical companies will continue to be provided with steady revenue-earning opportunities. Suchdemographic trends will remain the primary driver of growth behind the prescription drug markets thoughwe highlight that the government is likely to put further emphasis on promoting cost-reduction initiativesthat would be supportive of the generic medicines market, which would see the market share of patentedmedicines weaken.

Headline Expenditure Projections

Pharmaceuticals: SEK37.70bn (USD5.49bn) in 2014 to SEK37.83bn (USD4.38bn) in 2015; +0.34% inlocal currency terms and -20.3% in US dollar terms.

Healthcare: SEK362.42bn (USD52.81bn) in 2014 to SEK371.82bn (USD43.05bn) in2015; +2.6% inlocal currency terms and -18.5% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Sweden 2013-2019)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Sweden 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Sweden 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Sweden 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Sweden 2011-2019)
OTC Medicines Market Forecast
Table: OTC Sales by Therapeutic Group At Retail Prices, 2009-2010 (SEKmn)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Sweden 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Sweden 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Sweden 2013-2019)
Industry Risk/Reward Index
Western Europe Risk/Reward Index
Sweden Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Sweden 2009-2014)
Table: Healthcare Personnel (Sweden 2009-2014)
Table: Healthcare Activity (Sweden 2009-2014)
Research & Development
Table: Drug Development Member Companies of SwedenBIO, 2015
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Pharmaceutical Industry Developments
Table: Multinational Market Activity
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
AstraZeneca
Meda
Medivir
Novartis
Swedish Orphan Biovitrum (SOBI)
Demographic Forecast
Table: Population Headline Indicators (Sweden 1990-2025)
Table: Key Population Ratios (Sweden 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Sweden 1990-2025)
Table: Population By Age Group (Sweden 1990-2025)
Table: Population By Age Group % (Sweden 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report